WCLC: AstraZeneca, Daiichi Sankyo's Enhertu shows more phase 2 lung cancer promise

Retrieved on: 2021-01-29 07:07:30

Tags for this article:

Click the tags to see associated articles and topics

WCLC: AstraZeneca, Daiichi Sankyo's Enhertu shows more phase 2 lung cancer promise. View article details on hiswai:

Excerpt

Right now, there are no HER2-targeting drugs approved in non-small cell lung cancer, but partners AstraZeneca and Daiichi Sankyo are hoping to ...

Article found on: www.fiercepharma.com